Nicholas P. Johnson

Nicholas P. Johnson

Auto-generated profile, based on publicly available information

Nicholas P. Johnson

Department of Emergency and Hospital Medicine/University of South Florida, Morsani College of Medicine Lehigh Valley Health Network Allentown Pennsylvania USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2020 in JACEP Open
Verified
Journal Article
Open access
PDF file
MKMichele N. Karn
Michele N. Karn
NJNicholas P. Johnson
Nicholas P. Johnson
SYSusan K. Yaeger
Susan K. Yaeger
KFKimberly L. Fugok
Kimberly L. Fugok
Symptoms of coronavirus disease 2019 overlap with other important illnesses affecting young adults. We report a case of a 17‐year old male presenting to the emergency department in the midst of a pandemic with symptoms of coronavirus disease 2019. He had fever, dyspnea, chest pain, and myalgias, with bilateral infiltrates on chest radiograph, and developed septic shock secondary to infectious thromboembolic events. However, his blood cultures grew group G streptococcus secondary to his oropharyngeal infection, and he experienced an infectious thrombus in the internal jugular vein, consistent with the rare but well‐described Lemierre's syndrome. This case report calls attention to the importance of maintaining differential diagnoses and thereby minimizing the biases and assumptions that come with clinical care during a pandemic.

28 June 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMustafa M. Siddiq
Mustafa M. Siddiq
NJNicholas P. Johnson
Nicholas P. Johnson
YZYana Zorina
Yana Zorina
AYArjun Singh Yadaw
Arjun Singh Yadaw
CTCarlos A. Toro
Carlos A. Toro
RIRavi Iyengar
Ravi Iyengar
There are no known drugs or drug combinations that promote substantial central nervous system axonal regeneration after injury. We used systems pharmacology approaches to model pathways underlying axonal growth and identify a four-drug combination that regulates multiple subcellular processes in the cell body and axon using the optic nerve crush model in rats. We intravitreally injected agonists HU-210 (cannabinoid receptor-1) and IL-6 (interleukin 6 receptor) to stimulate retinal ganglion cells for axonal growth. We applied, in gel foam at the site of nerve injury, Taxol to stabilize growing microtubules, and activated protein C to clear the debris field since computational models predicted that this drug combination regulating two subcellular processes at the growth cone produces synergistic growth. Morphology experiments show that the four-drug combination promotes axonal regrowth to the optic chiasm and beyond. Physiologically, drug treatment restored pattern electroretinograms and some of the animals had detectable visual evoked potentials in the brain and behavioral optokinetic responses. We conclude that spatially targeted drug treatment can promote robust axonal regeneration and can restore limited functional recovery.